Track CapsoVision, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

CapsoVision, Inc. CV · Stock Open CapsoVision, Inc. in new tab

6.85 USD
EPS
-0.45
P/B
25.97
ROE
-335.06
Target Price
9.50 USD
Loading chart...
Key Metrics
Earnings dateNov. 12, 2026
EPS-0.45
Book Value0.26
Price to Book25.97
Debt/Equity5.22
% Insiders30.140%
Growth
Revenue Growth0.10%
Estimates
Target Mean Price9.50

DCF valuation

Model fair value for CapsoVision, Inc. (CV)
Result
Sign in to run the valuation for CV.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
2 analysts · consensus None · mean target 9.50 USD (low 9.00, high 10.00) · as of 2 Nov 2026
Low 9.00
Mean 9.50
High 10.00
Price 6.85
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

CapsoVision, Inc. Logo CapsoVision, Inc. Analysis (CV)

Is CapsoVision, Inc. a good investment? CapsoVision, Inc. (CV) is currently trading at 6.85 USD. Market analysts have a consensus price target of 9.50 USD. This suggests a potential upside from current levels.

Earnings Schedule: CapsoVision, Inc. is expected to release its next earnings report on Nov. 12, 2026.

Investor FAQ

Does CapsoVision, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is CapsoVision, Inc.?

CapsoVision, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -0.45.

Company Profile

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Exchange Ticker
CV
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion